The pharmacological management of childhood anxiety disorders: a review
The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Abstract
Rationale Pediatric anxiety is a prevalent psychiatric disorder that may have important implications for school, social, and academic function. Psychopharmacological approaches to the treatment of pediatric anxiety have expanded over the past 20 years and increasing empirical evidence helps guide current clinical practice.Objective To review studies which examine the pharmacological treatment of pediatric anxiety disorders, including obsessive-compulsive disorder and to summarize treatment implications.Methods All relevant studies were searched using MEDLINE and PsycINFO search engines, supplemented by a manual bibliographical search; studies published between 1985 and 2006 that met inclusion criteria were examined.Results This article provides a systematic review of the psychopharmacological treatment of pediatric anxiety disorders based on available empirical evidence, with a focus on randomized controlled trials. General treatment principles and pharmacological management of specific pediatric anxiety disorders are also reviewed.Conclusion There is good evidence to support the efficacy of several pharmacological agents including the selective serotonin reuptake inhibitors to treat pediatric anxiety and obsessive-compulsive disorder, although there are still many unanswered questions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reinblatt and Riddle [41] summarized the literature about pharmacological management of childhood anxiety disorders, finding that paroxetine is effective for children and adolescents dealing with SAD [42].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [42]
In the citing paper
“Overall, paroxetine was found to be significantly more effective than placebo in reducing the severity of SAD symptoms.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [42]
In the citing paper
“The most prevalent observed side effects of paroxetine were insomnia, decreased appetite and vomiting.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [42]
In the citing paper
“The results showed that the paroxetine group had a significantly higher response rate, as measured by the Clinical Global Impression-Improvement scale (CGI) [47], compared to the placebo group.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [42]
In the citing paper
“Furthermore, the reduction of symptoms through pharmacotherapy can lead to more functional behaviors, particularly in interpersonal processes, such as decreased avoidance and reduced social distress [27,42].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [42]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
SHAFFER, D., FISHER, P., LUCAS, C. P., DULCAN, M. K., & SCHWAB-STONE, M. E. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200001000-00014 · Cited by 3,505
Pine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.56 · Cited by 1,753
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738 · cited 10×
“The presence of both anxiety disorders and ADHD did not affect the utility of stimulants to treat ADHD in the MTA (Multimodal Treatment Study of Children with ADHD) study.”
BackgroundInfluentialTreating anxiety disorders in children: Results of a randomized clinical trial.
Kendall, P. C. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.62.1.100 · Cited by 1,376
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
A family study of obsessive–compulsive disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.76 · Cited by 1,022
Therapy for youths with anxiety disorders: A second randomized clincal trial.
Kendall, P. C., Flannery-Schroeder, E., Panichelli-Mindel, S. M., Southam-Gerow, M., Henin, A., & Warman, M. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.3.366 · Cited by 984 · cited 1×
“…SoP, as evidenced by a consistency of effect size (generally moderate-to-large) and efficacy in placebo-controlled trials (Birmaher et al. 2003; Kendall 1994; Kendall et al. 1997; Research Units for Pediatric Psychopharmacology (RUPP) Anxiety Study Group 2001; Rynn et al. 2001; Wagner et al. 2004).”
BackgroundADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups
JENSEN, P. S., HINSHAW, S. P., KRAEMER, H. C., LENORA, N., NEWCORN, J. H., ABIKOFF, H. B., MARCH, J. S., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00009 · Cited by 974 · cited 10×
“The presence of both anxiety disorders and ADHD did not affect the utility of stimulants to treat ADHD in the MTA (Multimodal Treatment Study of Children with ADHD) study.”
BackgroundInfluentialWhat Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 862
Obsessive Compulsive Disorder in Adolescence: An Epidemiological Study
FLAMENT, M. F., WHITAKER, A., RAPOPORT, J. L., DAVIES, M., BERG, C. Z., KALIKOW, K., SCEERY, W., & SHAFFER, D. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198811000-00018 · Cited by 684 · cited 2×
“1998), and a lifetime prevalence of 1– 3% (Douglass et al. 1995; Flament et al. 1988).”
BackgroundChild and Adolescent Psychiatry: Modern Approaches
Rutter, M. L., Taylor, E. A., & Hersov, L. (1987) · Medical Entomology and Zoology · Cited by 653
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1779 · Cited by 626
Traumas and Posttraumatic Stress Disorder in a Community Population of Older Adolescents
GIACONIA, R. M., REINHERZ, H. Z., SILVERMAN, A. B., PAKIZ, B., FROST, A. K., & COHEN, E. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199510000-00023 · Cited by 626
Anxiety Disorders in Children and Adolescents
March, J. S. (2005) · Pediatrics · doi:10.1016/b978-0-323-01199-0.50251-6 · Cited by 600
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L., Klein, R., Davies, M., Sweeney, M., Abikoff, H., Hack, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441703 · Cited by 588
Self-citationThe Pediatric Anxiety Rating Scale (PARS): development and psychometric properties
P, T. R. U. O. P. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200209000-00006 · Cited by 532
A community study of anxiety in children and adolescents
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.3.313 · Cited by 498
Child and Adolescent Psychiatry: Modern Approaches
Garralda, M. E. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.72.3.277-b · Cited by 484
March, J. S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E. H., Cutler, N. R., Dominguez, R., Ferguson, J., Muller, B., et al. (1998) · JAMA · doi:10.1001/jama.280.20.1752 · Cited by 469
Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-blind Controlled Study
Flament, M. F. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330057007 · Cited by 466 · cited 4×
“The doses in this study were lower than used in other clomipramine studies (DeVeaugh-Geiss et al. 1992; Flament et al. 1985; Leonard et al. 1989).”
BackgroundResultInfluentialUsing Numerical Results from Systematic Reviews in Clinical Practice
McQuay, H. J., & Moore, R. A. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-9-199705010-00007 · Cited by 455
Which SSRI? A Meta-Analysis of Pharmacotherapy Trials in Pediatric Obsessive-Compulsive Disorder
Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Martin, A., Spencer, T., & Faraone, S. V. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.11.1919 · Cited by 434
Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents
Olfson, M. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.10.978 · Cited by 430
Suicide Risk During Antidepressant Treatment
Simon, G. E., Savarino, J., Operskalski, B., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.41 · Cited by 424 · cited 2×
“So overall, there was no clear correlation between antidepressant medications and suicide (Simon et al. 2006); however, it is important for clinicians to inform parents and youths of this data suggesting some increased risk for suicidality.”
BackgroundRIDDLE, M. A., REEVE, E. A., YARYURA-TOBIAS, J. A., YANG, H. M., CLAGHORN, J. L., GAFFNEY, G., GREIST, J. H., HOLLAND, D., MCCONVILLE, B. J., PIGOTT, T., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00017 · Cited by 402
Self-citationThe Expert Consensus Guideline Series
Karceski, S., Morrell, M., & Carpenter, D. (2001) · Epilepsy & Behavior · doi:10.1006/ebeh.2001.0283 · Cited by 396
The Relationship Between Antidepressant Medication Use and Rate of Suicide
Gibbons, R. D., Hur, K., Bhaumik, D. K., & Mann, J. J. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.165 · Cited by 393
A Prospective Study of Childhood Anxiety Disorders
LAST, C. G., PERRIN, S., HERSEN, M., & KAZDIN, A. E. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199611000-00019 · Cited by 392
Children With Prepubertal-Onset Major Depressive Disorder and Anxiety Grown Up
Weissman, M. M., Wolk, S., Wickramaratne, P., Goldstein, R. B., Adams, P., Greenwald, S., Ryan, N. D., Dahl, R. E., & Steinberg, D. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.794 · Cited by 391
Alcohol dependence and anxiety disorders: what is the relationship?
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1723 · Cited by 386
Fluoxetine for the Treatment of Childhood Anxiety Disorders
BIRMAHER, B., AXELSON, D. A., MONK, K., KALAS, C., CLARK, D. B., EHMANN, M., BRIDGE, J., HEO, J., & BRENT, D. A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000037049.04952.9f · Cited by 385
Leonard, H. L. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810120030006 · Cited by 369
Research on the Treatment of Sexually Abused Children: A Review and Recommendations
FINKELHOR, D., & BERLINER, L. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199511000-00007 · Cited by 362
DEVEAUGH-GEISS, J., MOROZ, G., BIEDERMAN, J., CANTWELL, D., FONTAINE, R., GREIST, J. H., REICHLER, R., KATZ, R., & LANDAU, P. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00008 · Cited by 349
Obsessive-Compulsive Disorder in a Birth Cohort of 18-Year-Olds: Prevalence and Predictors
DOUGLASS, H. M., MOFFITT, T. E., DAR, R., McGEE, R., & SILVA, P. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199511000-00008 · Cited by 345
RIDDLE, M. A., SCAHILL, L., KING, R. A., HARDIN, M. T., ANDERSON, G. M., ORT, S. I., SMITH, J. C., LECKMAN, J. F., & COHEN, D. J. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199211000-00011 · Cited by 345
Self-citationLong-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation
Rickels, K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810220015002 · Cited by 332
The Pediatric Anxiety Rating Scale (PARS): Development and Psychometric Properties
Riddle, M., Ginsburg, G. S., Walkup, J., Labellarte, M. J., Pine, D. S., Davies, M., Greenhill, L., Sweeney, M., KLEIN, R. G., Abikoff, H., et al. (2002) · Institutional Research Information System University of Turin (University of Turin) · doi:10.1097/01.chi.0000020259.43550.f4 · Cited by 331
Self-citationKaufman, J., Birmaher, B., Brent, D. A., Ryan, N. D., & Rao, U. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200010000-00002 · Cited by 326
Rynn, M. A., Siqueland, L., & Rickels, K. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2008 · Cited by 321
GELLER, D. A., HOOG, S. L., HEILIGENSTEIN, J. H., RICARDI, R. K., TAMURA, R., KLUSZYNSKI, S., JACOBSON, J. G., & FLUOXETINE PEDIATRIC OCD STUDY TEAM (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00011 · Cited by 320
Tollefson, G. D. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070051010 · Cited by 314
Maternal and Environmental Influences on the Adrenocortical Response to Stress in Weanling Rats
Levine, S. (1967) · Science · doi:10.1126/science.156.3772.258 · Cited by 304
Propranolol Treatment for Childhood Posttraumatic Stress Disorder, Acute Type: A Pilot Study
Famularo, R. (1988) · American Journal of Diseases of Children · doi:10.1001/archpedi.1988.02150110122036 · Cited by 296
Lewinsohn, P. M., Zinbarg, R., Seeley, J. R., Lewinsohn, M., & Sack, W. H. (1997) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(97)00017-0 · Cited by 294
Treatment of Elective Mutism with Fluoxetine: A Double-Blind, Placebo-Controlled Study
BLACK, B., & UHDE, T. W. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199409000-00010 · Cited by 278
Levine, S., & Mullins, R. F. (1966) · Science · doi:10.1126/science.152.3729.1585 · Cited by 278
Comorbidity in Childhood Anxiety Disorders and Treatment Outcome
KENDALL, P. C., BRADY, E. U., & VERDUIN, T. L. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00013 · Cited by 277
Controlled Imipramine Treatment of School Phobia
Gittelman-Klein, R. (1971) · Archives of General Psychiatry · doi:10.1001/archpsyc.1971.01750150012002 · Cited by 276
Emotional Impact of Children's Exposure to Community Violence: A Preliminary Study
COOLEY-QUILLE, M. R., TURNER, S. M., & BEIDEL, D. C. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199510000-00022 · Cited by 269
March, J. S., Swanson, J. M., Arnold, L. E., Hoza, B., Conners, C. K., Hinshaw, S. P., Hechtman, L., Kraemer, H. C., Greenhill, L. L., Abikoff, H. B., et al. (2000) · Journal of Abnormal Child Psychology · doi:10.1023/a:1005179014321 · Cited by 250
Psychopathology from adolescence into young adulthood: an 8-year follow- up study
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1586 · Cited by 247
Pollack, M. H., Zaninelli, R., Goddard, A., McCafferty, J. P., Bellew, K. M., Burnham, D. B., & Iyengar, M. K. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0508 · Cited by 246
Wagner, K. D., Berard, R., Stein, M. B., Wetherhold, E., Carpenter, D. J., Perera, P., Gee, M., Davy, K., & Machin, A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1153 · Cited by 240 · cited 5×
“A study performed by Wagner examined the use of paroxetine in a large, industry-sponsored randomized, placebo-controlled 16-week trial for children and adolescents (N=322) with social anxiety disorder (Wagner et al. 2004).”
BackgroundMethodInfluential(2004) · Oxford University Press eBooks · doi:10.1093/med:psych/9780195135947.001.0001 · Cited by 238
GELLER, D. A., WAGNER, K. D., EMSLIE, G., MURPHY, T., CARPENTER, D. J., WETHERHOLD, E., PERERA, P., MACHIN, A., & GARDINER, C. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000138356.29099.f1 · Cited by 234
The Prospective Relation Between Dimensions of Anxiety and the Initiation of Adolescent Alcohol Use
Kaplow, J. B., Curran, P. J., Angold, A., & Costello, E. J. (2001) · Journal of Clinical Child & Adolescent Psychology · doi:10.1207/s15374424jccp3003_4 · Cited by 234
Achenbach, T. M., Howell, C. T., McConaughy, S. H., & Stanger, C. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199503000-00020 · Cited by 216
Imipramine Plus Cognitive-Behavioral Therapy in the Treatment of School Refusal
BERNSTEIN, G. A., BORCHARDT, C. M., PERWIEN, A. R., CROSBY, R. D., KUSHNER, M. G., THURAS, P. D., & LAST, C. G. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200003000-00008 · Cited by 216
Pliszka, S. R., GREENHILL, L. L., Crismon, M. L., Sedillo, A., Carlson, C. L., Conners, C. K., McCracken, J. T., Swanson, J. M., Hughes, C. W., LLANA, M. E., et al. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200007000-00021 · Cited by 207
Clonidine for Posttraumatic Stress Disorder in Preschool Children
HARMON, R. J., & RIGGS, P. D. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199609000-00022 · Cited by 205
Imipramine Treatment of Children with Separation Anxiety Disorder
KLEIN, R. G., KOPLEWICZ, H. S., & KANNER, A. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00005 · Cited by 201 · cited 2×
“The larger number needed to treat in this second study (Klein et al. 1992) also supports a less effective treatment effect than in the earlier study with a much lower number needed to treat (Gittleman-Klein and Klein 1971).”
BackgroundResultSchool Phobia: A Therapeutic Trial with Clomipramine and Short-Term Outcome
Berney, T., Kolvin, I., Bhate, S. R., Garside, R. F., Jeans, J., Kay, B., & Scarth, L. (1981) · British Journal of Psychiatry · doi:10.1192/bjp.138.2.110 · Cited by 198
Anxiety disorders in children and adolescents
Black, B. (1995) · Current Opinion in Pediatrics · doi:10.1097/00008480-199508000-00008 · Cited by 192
MUÑOZ, R. A. (2002) · American Journal of Psychiatry · doi:10.1176/ajp.159.6.1066 · Cited by 189
Fluoxetine Treatment of Children with Selective Mutism: An Open Trial
DUMMIT, E. S., KLEIN, R. G., ASCHE, B., MARTIN, J., & TANCER, N. K. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199605000-00016 · Cited by 188
Fluoxetine in Children and Adolescents With OCD: A Placebo-Controlled Trial
LIEBOWITZ, M. R., TURNER, S. M., PIACENTINI, J., BEIDEL, D. C., CLARVIT, S. R., DAVIES, S. O., GRAAE, F., JAFFER, M., LIN, S.-H., SALLEE, F. R., et al. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200212000-00014 · Cited by 188
Rynn, M. A., Riddle, M. A., Yeung, P. P., & Kunz, N. R. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.290 · Cited by 188
Self-citationGeller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Farrell, C., Wagner, K. D., Emslie, G., & Carpenter, D. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322126313 · Cited by 187
Comparative Studies of Pharmacotherapy for School Refusal
BERNSTEIN, G. A., GARFINKEL, B. D., & BORCHARDT, C. M. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199009000-00016 · Cited by 186
Case Study: Elective Mutism as a Variant of Social Phobia
BLACK, B., & UHDE, T. W. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199211000-00015 · Cited by 179
Comorbidity and Severity of Anxiety and Depressive Disorders in a Clinic Sample
Bernstein, G. A. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199101000-00007 · Cited by 179
Bernstein, G. A., & Shaw, K. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199710001-00006 · Cited by 177
SIMEON, J. G., FERGUSON, H. B., KNOTT, V., ROBERTS, N., GAUTHIER, B., DUBOIS, C., & WIGGINS, D. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00006 · Cited by 177
Clonazepam in Childhood Anxiety Disorders
GRAAE, F., MILNER, J., RIZZOTTO, L., & KLEIN, R. G. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199403000-00011 · Cited by 176
Davidson, J. R. T., Bose, A., Korotzer, A., & Zheng, H. (2004) · Depression and Anxiety · doi:10.1002/da.10146 · Cited by 175
Allgulander, C., Hackett, D., & Salinas, E. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.1.15 · Cited by 175 · cited 2×
“2003), as have serotonin-norepinephrine reuptake inhibitors (SNRI) like venlafaxine (Allgulander et al. 2001; Brawman-Mintzer 2001).”
BackgroundMethodStability and Natural History of DSM-III Childhood Diagnoses
CANTWELL, D. P., & BAKER, L. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198909000-00009 · Cited by 167
Depression, Family Environment, and Adolescent Suicidal Behavior
Hollis, C. P. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199605000-00017 · Cited by 167
ROBERT, R., BLAKENEY, P. E., VILLARREAL, C., ROSENBERG, L., & MEYER, W. J. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199907000-00018 · Cited by 162
Treatment of ADHD with Fluoxetine: A Preliminary Trial
Barrickman, L., Noyes, R., Kuperman, S., Schumacher, E., & Verda, M. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/s0890-8567(10)80011-5 · Cited by 158
Treatment of School Refusal: One-Year Follow-up
Bernstein, G. A., Hektner, J. M., BORCHARDT, C. M., & MCMILLAN, M. H. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00015 · Cited by 158
Pediatric Stimulant and Selective Serotonin Reuptake Inhibitor Prescription Trends: 1992 to 1998
Rushton, J. L., & Whitmire, J. T. (2001) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.155.5.560 · Cited by 153
Abikoff, H., McGough, J. J., Vitiello, B., McCracken, J. T., Davies, M., Walkup, J. T., Riddle, M. A., Oatis, M. D., Greenhill, L. L., Skrobala, A. M., et al. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000155320.52322.37 · Cited by 149
Self-citationDepression, antidepressants and suicidality: a critical appraisal
Licinio, J., & Wong, M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1634 · Cited by 146
Efficacy of Sertraline in a 12-Week Trial for Generalized Anxiety Disorder
Allgulander, C., Dahl, A. A., Austin, C., Morris, P. L. P., Sogaard, J. A., Fayyad, R., Kutcher, S. P., & Clary, C. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1642 · Cited by 139
Salivary cortisol levels in socially phobic adolescent girls
Martel, F. L., Hayward, C., Lyons, D. M., Sanborn, K., Varady, S., & Schatzberg, A. F. (1999) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1999)10:1<25::aid-da4>3.0.co;2-o · Cited by 130
Efficacy and Tolerability of Paroxetine for the Long-Term Treatment of Generalized Anxiety Disorder
Stocchi, F., Nordera, G., Jokinen, R. H., Lepola, U. M., Hewett, K., Bryson, H., Iyengar, M. K., & Paroxetine Generalized Anxiety Disorder Study Team (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0305 · Cited by 128
Pliszka, S. R., GREENHILL, L. L., Crismon, M. L., Sedillo, A., Carlson, C. L., Conners, C. K., McCracken, J. T., Swanson, J. M., Hughes, C. W., LLANA, M. E., et al. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200007000-00022 · Cited by 124
Panic Disorder and Agoraphobia in Consecutively Referred Children and Adolescents
Biederman, J., Faraone, S. V., Marrs, A. L., Moore, P. S., García, J. M., Ablon, S., Mick, E. O., Gershon, J., & KEARNS, M. E. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199702000-00012 · Cited by 117
Open Fluoxetine Treatment of Mixed Anxiety Disorders in Children and Adolescents
FAIRBANKS, J. M., PINE, D. S., TANCER, N. K., DUMMIT, E. S., KENTGEN, L. M., MARTIN, J., ASCHE, B. K., & KLEIN, R. G. (1997) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1997.7.17 · Cited by 116
Brent, D. A., Perper, J. A., MORITZ, G., Liotus, L., Richardson, D., CANOBBIO, R., SCHWEERS, J., & Roth, C. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199502000-00016 · Cited by 114
Anxiety disorders in adolescence: Characteristics, prevalence, and comorbidities
Clark, D. B., Smith, M. G., Neighbors, B., Skerlec, L. M., & Randall, J. (1994) · Clinical Psychology Review · doi:10.1016/0272-7358(94)90012-4 · Cited by 113
The treatment of anxiety disorders in children and adolescents
Labellarte, M. J., Ginsburg, G. S., Walkup, J. T., & Riddle, M. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00248-6 · Cited by 112
Self-citationNeurobiological sequelae of childhood trauma: PTSD in children.
Perry, B. D. (1994) · Cited by 107
Sertraline in Children and Adolescents With Social Anxiety Disorder: An Open Trial
Compton, S. N., GRANT, P. J., Chrisman, A. K., GAMMON, P. J., BROWN, V. L., & March, J. S. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200105000-00016 · Cited by 107
Fluoxetine for the Treatment of Social Phobia
BLACK, B., UHDE, T. W., & TANCER, M. E. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199208000-00022 · Cited by 106
Looff, D. H., Grimley, P., Kuller, F. E., Martin, A. P., & Shonfield, L. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199506000-00008 · Cited by 104
Pediatric Psychopharmacology: Principles and Practice.
Abright, A. R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000132814.52288.38 · Cited by 101
Berk, M. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.t01-3-01063.x-i1 · Cited by 97
Anxiolytics, Adrenergic Agents, and Naltrexone
Riddle, M. A., Bernstein, G. A., Cook, E. H., Leonard, H. L., March, J. S., & Swanson, J. M. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199905000-00016 · Cited by 94
Self-citationChild and Adolescent Clinical Psychopharmacology
Green, W. H. (1991) · Cited by 92
Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence
(2008) · National Academies Press eBooks · doi:10.17226/11955 · Cited by 90
(2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386879 · Cited by 89
Self-citationNorrholm, S. D., & Ouimet, C. C. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02909-7 · Cited by 83
WEGERER, V., MOLL, G. H., BAGLI, M., ROTHENBERGER, A., RÜTHER, E., & HUETHER, G. (1999) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1999.9.13 · Cited by 83
Garland, E. J., & Baerg, E. A. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750284090 · Cited by 80
Pine, D. S. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386888 · Cited by 73
Sertraline Treatment of 5 Children Diagnosed with Selective Mutism: A Single-Case Research Trial
CARLSON, J. S., KRATOCHWILL, T. R., & JOHNSTON, H. F. (1999) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1999.9.293 · Cited by 70
Double-blind placebo-controlled pilot study of paroxetine for specific phobia
Benjamin, J., Ben-Zion, I. Z., Karbofsky, E., & Dannon, P. N. (2000) · Psychopharmacology · doi:10.1007/s002130000372 · Cited by 68
The Pharmacotherapy of Anxiety Disorders in Children and Adolescents
Kutcher, S., Reiter, S., Gardner, D. M., & Klein, R. G. (1992) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30257-0 · Cited by 67
New Treatment for Chronic Myelogenous Leukemia
Schwetz, B. A. (2001) · JAMA · doi:10.1001/jama.286.1.35 · Cited by 67
Paroxetine, Other Antidepressants, and Youth Suicide in New York City: 1993 Through 1998
Leon, A. C., Marzuk, P. M., Tardiff, K., & Teres, J. J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0706 · Cited by 66
Complications of SSRI Treatment
Walkup, J. T., & Labellarte, M. J. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750143320 · Cited by 64
Panic Disorder in Clinically Referred Children and Adolescents
Masi, G., Favilla, L., Mucci, M., & Millepiedi, S. (2000) · Child Psychiatry & Human Development · doi:10.1023/a:1001948610318 · Cited by 61
Case Study: Fluoxetine in the Multimodal Treatment of a Preschool Child with Selective Mutism
Wright, H. H., Cuccaro, M. L., Leonhardt, T. V., Kendall, D., & ANDERSON, J. H. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199507000-00008 · Cited by 60
Anxiety attacks with subsequent agoraphobia
Mendel, J. G., & Klein, D. F. (1969) · Comprehensive Psychiatry · doi:10.1016/0010-440x(69)90031-5 · Cited by 60
Pharmacologic Treatment of Anxiety Disorders in Children and Adolescents
Velosa, J. F., & Riddle, M. A. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30138-x · Cited by 57
Self-citationA controlled clinical trial of alprazolam for the treatment of anxiety
(1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.1.82 · Cited by 56
Pharmacologic Treatment of Obsessive Compulsive Disorders *
Jenike, M. A. (1992) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30217-x · Cited by 48
RENAUD, J., BIRMAHER, B., WASSICK, S. C., & BRIDGE, J. (1999) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1999.9.73 · Cited by 46
Diagnosis of Panic Disorder in Prepubertal Children
Vitiello, B., Béhar, D., WOLFSON, S., & McLeer, S. V. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199009000-00017 · Cited by 45
Manassis, K., & Monga, S. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200101000-00024 · Cited by 42
Depression in anxious children: Possible factors in comorbidity
Manassis, K., & Menna, R. (1999) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1999)10:1<18::aid-da3>3.0.co;2-r · Cited by 42
Pharmacologic Treatment of Generalized Anxiety Disorder
Brawman‐Mintzer, O. (2001) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70209-4 · Cited by 41
Psychopharmacologic Treatment of Pediatric Anxiety Disorders
Reinblatt, S. P., & Walkup, J. T. (2005) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.06.004 · Cited by 38
Self-citationSelective Serotonin Reuptake Inhibitor-Induced Apathy: A Pediatric Case Series
Reinblatt, S. P., & Riddle, M. A. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.227 · Cited by 36
Self-citationSelective Serotonin Reuptake Inhibitor–Induced Sexual Dysfunction in Adolescents: A Review
Scharko, A. M. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000131135.70992.58 · Cited by 36
Pharmacokinetics of Benzodiazepines and Psychostimulants in Children
Coffey, B. J., Shader, R. I., & Greenblatt, D. J. (1983) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198308000-00003 · Cited by 35
Childhood-Onset Panic Disorder
Birmaher, B. B., & Ollendick, T. H. (2004) · Oxford University Press eBooks · doi:10.1093/med:psych/9780195135947.003.0011 · Cited by 30
Preoccupation with suicide in patients treated with fluoxetine
Downs, J. M., Ward, J., & Farmer, R. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.8.1090b · Cited by 28
Disinhibition and Anger Outbursts in Adolescents Treated with Clonazepam
Reiter, S., & Kutcher, S. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199108000-00016 · Cited by 26
Safer, D. J. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0215 · Cited by 26
Resolution of Fear of Flying with Fluoxetine Treatment
Abene, M. V., & Hamilton, J. D. (1998) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(98)00036-x · Cited by 24
Domon, S. E., & Andersen, M. S. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200008000-00003 · Cited by 24
Pine, D. S. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199402000-00019 · Cited by 22
Cohen, J. A., & Mannarino, A. P. (2004) · Oxford University Press eBooks · doi:10.1093/med:psych/9780195135947.003.0014 · Cited by 19
Pediatric Psychopharmacology: Principles and Practice
Varley, C. K., & Calinoiu, I. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.10.1035-b · Cited by 18
Psychopharmacology Interventions for Pediatric Anxiety Disorders: A Research Update
Waslick, B. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.08.009 · Cited by 17 · cited 2×
“The paucity of large randomized studies in childhood PD is likely related to the low prevalence ( Waslick 2006 ), and may also be due to an altered clinical presentation leading to”
BackgroundChild and Adolescent Psychiatry: Modern Approaches, Third Edition
Rutter, M. L., Taylor, E., & Hersov, L. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · Cited by 14
Does Panic Disorder Exist in Childhood?
Klein, D. F., & KLEIN, R. G. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199009000-00026 · Cited by 9
Schwetz, B. A. (2002) · JAMA · doi:10.1001/jama.287.9.1103-jfd20003-2-1 · Cited by 9
Emotional blunting, sexual dysfunction and SSRIs
Balon, R. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003127 · Cited by 8
Schwetz, B. A. (2002) · JAMA · doi:10.1001/jama.287.9.1103 · Cited by 7
SSRI-INDUCED SEXUAL DYSFUNCTION IN ADOLESCENTS
Scharko, A. M., & Reiner, W. G. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000132832.05219.65 · Cited by 7
Drug for Pediatric Liver Disease
Schwetz, B. A. (2002) · JAMA · doi:10.1001/jama.287.9.1103-jfd20003-3-1 · Cited by 5
Child and adolescent clinical psychopharmacology
Reimão, R. (1997) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x1997000200037 · Cited by 4
Research works printed but not linked: 3
- American Medical Association (2001) International classification of diseases, 9th revision, clinical modification physician ICD-9-CM, 2002, vol 1 and 2. AMA Press, Chicago, IL (color-coded, illustrated, annotated)
- Labellarte M, Ginsburg GS (2003) Anxiety disorders. In: Martin A, Scahill L, Charney D et al (eds) Pediatric psychopharmacology: principles and practice. Oxford University Press, New York, pp 496–510
- Viswanathan R, Paradis C (1991) Treatment of cancer phobia with fluoxetine. Am J Psychiatry 148:1090
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Assessment and Treatment of Anxiety Disorders in Children and Adolescents
Wehry, A. M., Beesdo-Baum, K., Hennelly, M. M., Connolly, S. D., & Strawn, J. R. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0591-z · Cited by 294
MCCORMICK, C., SMITH, C., & MATHEWS, I. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.09.005 · Cited by 278
Andrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O., Rapee, R., & Wilkins, G. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418799453 · Cited by 243
Fear and missing out: Youth anxiety and functional outcomes.
Swan, A. J., & Kendall, P. C. (2016) · Clinical Psychology: Science and Practice · doi:10.1111/cpsp.12169 · Cited by 198
Metadata
- Authors
- Reinblatt, S. P., & Riddle, M. A.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Reinblatt, Shauna P.
- Venue
- Psychopharmacology
- Published
- 2007-01-05
- Volume
- 191
- Issue
- 1
- Pages
- 67-86
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2108623420
- Cited by
- 67
- References
- 152
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2018: 4 · 2017: 2 · 2016: 1 · 2015: 8 · 2014: 4 · 2013: 3 · 2012: 8
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- childhood anxiety disorders, pharmacotherapy, obsessive-compulsive disorder, selective serotonin reuptake inhibitors, children, randomized controlled trials, treatment efficacy
- MeSH terms
- Adolescent, Psychology, Adolescent, Antidepressive Agents, Tricyclic, Anxiety Disorders, Child, Psychology, Child, Drug Administration Schedule, Drug Resistance, Humans, Mutism, Obsessive-Compulsive Disorder, Phobic Disorders, Stress Disorders, Post-Traumatic, Anti-Anxiety Agents, Panic Disorder, Treatment Outcome, Treatment Failure, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.